Strength in Analytical Instruments and Specialty Diagnostics segments is likely to have driven Thermo Fisher's first-quarter 2025 performance.

Discover how a structural breakthrough in the chikungunya virus is opening new avenues for antiviral drug development and ...

A common lithium salt has revealed new possibilities for manufacturing cheaper, longer-lasting battery materials.

Thermo Fisher Scientific is slated to announce its Q1 earnings on April 23, with analysts eyeing $5.11 EPS and $10.23 billion ...

But one aspect – the texture of the metals used – has been historically overlooked.

Thermo Fisher shares just pulled an 8.2% power move, closing at $453.55, and investors are buzzing louder than a centrifuge.

At PNNL, scientists have applied this process to lithium oxide (Li2O). They found that when Li2O is sublimated at sea-level ...

A new collaboration facility, opened by Thermo Fisher Scientific, will work to make cell therapy developers’ research more accessible and optimized.

Thermo Fisher Scientific shows strong fundamentals, consistent earnings growth, and solid financial health, making it a ...

In the US, healthcare costs and prices have been increasing. According to the Centers for Medicare & Medicaid Services, U.S.

The GeneTitan® family of instruments and proven GeneChip® Array Plates from Thermo Fisher Scientific are the first to provide a hands-free, automated solution for monitoring gene expression and ...